LEADER 04891nam  2200673 a 450 
001 9910456172603321
005 20200520144314.0
010   $a1-280-20397-8
010   $a9786610203970
010   $a0-309-56427-1
010   $a0-585-03808-2
035   $a(CKB)111069351109030
035   $a(EBL)3377126
035   $a(SSID)ssj0000205210
035   $a(PQKBManifestationID)11200651
035   $a(PQKBTitleCode)TC0000205210
035   $a(PQKBWorkID)10192427
035   $a(PQKB)11095424
035   $a(MiAaPQ)EBC3377126
035   $a(Au-PeEL)EBL3377126
035   $a(CaPaEBR)ebr10068358
035   $a(CaONFJC)MIL20397
035   $a(OCoLC)923268432
035   $a(EXLCZ)99111069351109030
100   $a19910325d1991      ua             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aMonitoring human tissues for toxic substances$b[electronic resource] /$fCommittee  on National Monitoring of Human Tissues, Board on Environmental Studies and Toxoicology, Commission on Life Sciences
210   $aWashington, D.C. $cNational Academy Press$d1991
215   $a1 online resource (224 p.)
300   $aDescription based upon print version of record.
311   $a0-309-04437-5 
320   $aIncludes bibliographical references (p. 167-178).
327   $a""Monitoring Human Tissues for Toxic Substances""; ""Copyright""; ""Preface""; ""Contents""; ""Executive Summary""; ""THE NATIONAL HUMAN MONITORING PROGRAM""; ""CHARGE TO THE COMMITTEE""; ""RELATIONSHIP OF TISSUE MONITORING TO EPA PROGRAM PRIORITIES""; ""GOALS AND POTENTIAL USES OF A NATIONAL PROGRAM TO MONITOR HUMAN TISSUES""; ""CONCLUSIONS AND RECOMMENDATIONS""; ""Toxicologic Issues""; ""Relevance of Human Tissue Monitoring to Risk Assessment""; ""Choice of Tissues to Monitor""; ""Sampling Methods""; ""Collection, Short-Term Storage, and Archiving of Tissues""
327   $a""Chemical Assay of Specimens""""Program Design and Management Issues""; ""Administrative and Agency Issues""; ""Funding""; ""Science Review""; ""Other Administrative Issues""; ""Analysis and Reporting of Data""; ""Cooperation and Information Transfer with Other Organizations""; ""Monitoring Human Tissues for Toxic Substances""; ""1 Introduction ""; ""BACKGROUND""; ""CHARGE TO THE COMMITTEE""; ""ENVIRONMENTAL AND PUBLIC HEALTH RATIONALE FOR MONITORING CHEMICALS IN HUMAN TISSUES""; ""RELATIONSHIP OF TISSUE MONITORING TO EPA PROGRAM PRIORITIES""
327   $a""GOALS AND POTENTIAL USES OF A NATIONAL PROGRAM TO MONITOR HUMAN TISSUES""""2 Review of the National Human Adipose Tissue Survey and Selected Program Alternatives ""; ""DEVELOPMENT OF THE PROGRAM""; ""Program Deficiencies""; ""Toxicologic Issues (see Chapter 3)""; ""Sampling Strategy (See Chapter 4)""; ""Collection, Storage, and Archiving of Tissues (see Chapter 5)""; ""Chemical Assay Issues (see Chapter 6)""; ""Programmatic Issues (see Chapter 7)""; ""EXISTING PROGRAMS AS POSSIBLE ALTERNATIVES TO THE NATIONAL HUMAN ADIPOSE TISSUE SURVEY""
327   $a""National Center for Health Statistics: National Health and Nutrition Examination Surveys (NHANES)""""Agency for Toxic Substances and Disease Registry: National Exposure and Disease Registries""; ""National Institute of Standards and Technology: Environmental Specimen Banking Program""; ""Environmental Protection Agency: Total Exposure Assessment Methodology Study""; ""Food and Drug Administration: Total-Diet Study""; ""National Oceanographic and Atmospheric Administration: National Status and Trends Mussel Watch Program""; ""Foreign Programs""; ""Conclusions""
327   $a""SUMMARY AND RECOMMENDATIONS""""3 Toxicologic Issues ""; ""INTRODUCTION""; ""RELATION BETWEEN ENVIRONMENTAL MONITORING AND TISSUE MONITORING""; ""RELEVANCE OF HUMAN TISSUE MONITORING TO RISK ASSESSMENT""; ""Biologic Markers""; ""Markers of Exposure or Dose""; ""Markers of Effect""; ""Markers of Biologically Effective Dose""; ""Markers of Early Biologic Effect""; ""Markers of Susceptibility""; ""Summary""; ""CHOICE OF TISSUES TO MONITOR""; ""Background""; ""Blood""; ""Adipose Tissue""; ""Lean Tissues""; ""Biologic Fluids""; ""Hair""; ""SUMMARY AND RECOMMENDATIONS""; ""4 Sampling Methods ""
327   $a""INTRODUCTION""
606   $aBiological monitoring$zUnited States
606   $aBlood$xAnalysis$zUnited States
606   $aAdipose tissues$xAnalysis$zUnited States
606   $aHealth risk assessment
608   $aElectronic books.
615  0$aBiological monitoring
615  0$aBlood$xAnalysis
615  0$aAdipose tissues$xAnalysis
615  0$aHealth risk assessment.
676   $a615.9/07
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910456172603321
996   $aMonitoring human tissues for toxic substances$92109260
997   $aUNINA